Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by skier59on Dec 30, 2020 6:46pm
124 Views
Post# 32200343

RE:RE:RE:RE:RE:RE:RE:Patience with this one

RE:RE:RE:RE:RE:RE:RE:Patience with this oneNo you have it all wrong. You need 8 warrants to buy 1 share. Right now it seems odd because you look at the short term. Let's say you are thinking I buy 8,000 warrants @ 6 cents. Those 8,000 warrants are really only 1000 shares when you exercise them, so today it doesn't seem to make sense, because your break-even price is now, current SP 73 cents + exercise price 72 cents= $1.45 per share. It is only after the SP breaks above $1.45 that you will start to see the exponential growth of warrants. It seems they might be too confusing for you and perhaps you should stay in the shares. Consolidation makes it somewhat confusing, so don't feel insulted. You have to believe in the companies potential if you want to venture into their warrants. It is certainly more risky, and that is why it offers are bigger payout if all goes as planned ! To profit on warrants you have to get in early, before the SP breaks out, like now.


BoredAccountGuy wrote:
exactly. So each warrant for 5.5 cents is an option to buy the stock at 72 cents You don't need 8 warrants plus 72 cents to buy 1 stock that would make no sense


<< Previous
Bullboard Posts
Next >>